Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Preprint.

Nav

General Info

Geography

France (FRA)

Time period covered

01/2020 - 12/2020

Data type

Scientific literature

Keywords

Blood tests, COVID-19, Disease outbreaks

Citation

Authors

Journal

medRxiv

Publication year

2020

Suggested citation

Vu SL, Jones G, Anna F, Rose T, Richard J-B, Bernard-Stoecklin S, Goyard S, Demeret C, Helynck O, Robin C, Monnet V, Facci LP de, Ungeheuer M-N, Léon L, Guillois Y, Filleul L, Charneau P, Lévy-Bruhl D, van der Werf S, Noel H. Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Preprint. medRxiv. 2020.

GHDx Entry last modified on: May 12, 2022

Header sites

Search form

Main menu

Prevalence of SARS-CoV-2 antibodies in France: results from nationwide serological surveillance. Preprint.

Nav